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1,2-Benzoxathiin-4(3H)-one 2,2-dioxide –  
an underinvestigated building block with a high  
synthetic and pharmacological potential:  
synthesis, chemical properties,  
biological activity
Aim. To analyze the available literature data on the methods of synthesis, chemical transformations and 
the biological activity of derivatives containing a sultone core – 1,2-benzoxathiin-4(3H)-one 2,2-dioxide – and to 
show the possibilities of their further use in the construction of new molecular systems with attractive pharma-
cological properties.
Results and discussion. The most widespread method for the synthesis of 1,2-benzoxathiin-4(3H)-one 
2,2-dioxides is the cyclization of salicylic acid derivatives. The known chemical transformations of 1,2-benzoxathiin-
4(3H)-one 2,2-dioxides deal with all reaction centers of the heterocyclic fragment of the condensed system 
– C=O and CH2 groups, SO2–O bond, CH2CO fragment as a whole. It should be noted that the oxathiine nu-
cleus is prone to undergo recyclizations. The use of 1,2-benzoxathiin-4(3H)-one 2,2-dioxides in multicomponent 
transformations still remains hardly explored. The “abnormal” course of some classical transformations involving 
1,2-benzoxathiine 2,2-dioxides is also noteworthy. The study of the pharmacological properties of 1,2-benzox-
athiin-4(3H)-one 2,2-dioxide derivatives is scarce and mainly based on their structural similarity to the coumarin 
core, which led to the study of anticoagulant, antimicrobial and antitumor properties for the sultone derivatives.
Conclusions. The analysis has shown a limited number of studies in each aspect – approaches to the syn-
thesis of 1,2-benzoxathiin-4(3H)-one 2,2-dioxides, their chemical transformations and the study of their phar-
macological activity. In addition to a small number of publications on this heterocyclic system, there have been 
almost no sultone studies in the last 20 years. Taking this into account 1,2-benzoxathiin-4(3H)-one 2,2-dioxide 
and its derivatives deserve close attention as objects of research for experimental chemistry and pharmacology.
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1,2-Бензоксатіїн-4(3Н)-он 2,2-діоксид – малодосліджений білдинг-блок  
із високим синтетичним та фармакологічним потенціалом:  
синтез, хімічні властивості, біологічна активність
Мета. Проаналізувати наявні літературні дані щодо методів синтезу, хімічних перетворень та біологіч-
ної активності похідних, які містять у своєму складі ядро сультону – 1,2-бензоксатіїн-4(3Н)-он 2,2-діоксиду 
та показати можливості їх подальшого використання у побудові нових молекулярних систем з привабли-
вими фармакологічними властивостями.
Результати та їх обговорення. Найбільш популярний метод для синтезу ядра 1,2-бензоксатіїн-4(3Н)-он  
2,2-діоксидів – циклізація похідних саліцилової кислоти. Відомі хімічні перетворення 1,2-бензоксатіїн-4(3Н)-
он 2,2-діоксидів зачіпають усі реакційні центри гетероциклічного фрагмента конденсованої системи – С=О та 
СН2 групи, SO2-O зв’язок та CH2CO фрагмент у цілому. Варто зазначити, що оксатіїнове ядро схильне до 
рециклізаційних перетворень. Використання 1,2-бензоксатіїн-4(3Н)-он 2,2-діоксидів у багатокомпонентних 
перетвореннях досі залишається майже не дослідженим. Також звертає на себе увагу «аномальний» пере-
біг деяких класичних перетворень за участю 1,2-бензоксатіїн 2,2-діоксидів. Дослідження фармакологічних 
властивостей похідних 1,2-бензоксатіїн-4(3Н)-он 2,2-діоксиду носить одиничний характер та базується 
на їх структурній схожості з ядром кумарину, що зумовило вивчення антикоагулянтних, протимікробних та 
протипухлинних властивостей для похідних цього сультону.
Висновки. Проведений аналіз засвідчив обмежену кількість досліджень щодо кожного аспекту – під-
ходів до синтезу 1,2-бензоксатіїн-4(3Н)-он 2,2-діоксидів, вивчення їх хімічних перетворень та фармаколо-
гічної активності. Окрім незначної кількості публікацій, де висвітлено особливості цієї гетероциклічної сис-
теми, останні 20 років майже немає робіт з досліджень сультону. З огляду на це, 1,2-бензоксатіїн-4(3Н)-он 
2,2-діоксид та його похідні заслуговують на пильну увагу як об’єкти дослідження для експериментальної 
хімії та фармакології.
Ключові слова: сультон; оксатіїн; гетероциклізація; метиленактивні кетони; біологічна активність
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Nowadays, organic chemistry deals with an incre- 
dible number of molecular platforms, and it is extre- 
mely difficult to find a relatively simple organic com-
pound, which is underinvestigated with respect to its 
chemical and/or biological properties. Nevertheless, 
1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) appeared 
to be one of such ‘dark places’ in organic chemistry 
(Fig. 1). To date, chemical databases provide only about 
20 works concerning benzoxathiinone 1. Moreover, 
issues of the biological activity and multicomponent 
interactions for it have been hardly studied until now. 
Such a state of affairs is strange as compound 1 com-
prises two attractive structural moieties. The first one 
is a b-keto sulfone fragment that allows a molecule 
to be a versatile synthetic intermediate used for the pre- 
paration of diverse classes of organic compounds [1]. 
The second one is a sultone fragment, which is re-
sponsible for many kinds of pharmacological activi-
ties mainly concerned with their toxicological, skin 
sensitization, antiviral, carbonic anhydrase inhibitory 
properties, etc. [2 – 4]. Furthermore, in recent decades 
sultones have become valuable scaffolds widely used 
as building blocks in the field of medicinal chemistry 
and were described in several reviews [5, 6].
Besides, benzoxathiinone 1 may gain the additio- 
nal value due to its isosteric relationships. At the begin-
ning of the XXth century the concept of isosterism be-
came especially relevant in medical chemistry. It still 
remains a powerful tool for the purposeful search of 
new biologically active substances [7, 8]. The isosteric 
replacement changes one or more characteristics of 
the molecule: size, shape, hydrophobicity, solubility, 
pKa, reactivity. Such changes make it possible to in-
crease the selectivity of the compound, reduce its side 
effects and toxicity, improve pharmacokinetic charac-
teristics and increase the metabolic stability. From 
this point of view, 1,2-benzoxathiin-4(3H)-one 2,2-di- 
oxide (1) core can be considered as isostere, first of all, 
to such a well-known pharmacophore as 4-hydroxy- 
coumarin A (Fig. 2). Among the derivatives of the lat-
ter there are anticoagulants of the indirect action, vi-
tamin K inhibitors – warfarin, dicoumarol and others [9]. 
Secondly, the structural analog of this compound is 
1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide B, which 
derivatives have shown high efficacy in the treatment 
of pain and inflammation, and even greater activity 
compared to such known NSAIDs as Piroxicam® and 
Meloxicam® [10, 11].
This review focuses on developments in chemistry 
and pharmacology of 1,2-benzoxathiin-4(3H)-one 2,2- 
dioxide (1) derivatives, including our achievements 
in this field. We hope the review will encourage, guide 
and intensify further research in the topic of sultone 
1, resulting in a breakthrough in the search for new 
medicines.
Results and discussion
A lot of methods have been developed for the pre- 
paration of sultones. The classical approach to their 
synthesis is the intramolecular cyclization of aromatic 
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almost complete absence of
bioactivity data for its derivatives
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Fig. 2 Isosteric relationships of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) with 4-hydroxycoumarin A  
and 1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide B
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hydroxysulfonic acids under the action of the concentra- 
ted sulfuric acid, phosphorus pentachloride or phos-
phorus oxychloride [12]. Other methods involve the intra-
molecular Diels-Alder reaction of vinyl sulfonates [13], 
sulfonate metathesis reactions [14, 15], the cycliza-
tion reactions of sulfonates using organometallic ca- 
talysts containing copper, palladium, rhodium, ruthe-
nium, etc. [12, 16, 17]. According to these methods 
sultons with different cycle sizes, mono- and polycyc- 
lic, saturated, unsaturated and condensed with aro-
matic systems can be synthesized.
Regarding the approaches to the synthesis of sul-
tone 1 some works describe the methods where it was 
not the targeted one or turned out to be an unexpec- 
ted product of another interaction studied. An examp- 
le of such transformations is the acidic hydrolysis of 
2-hydroxy-α-sulfamoylacetophenone (3) presented 
by the authors Uno et al. [18]. In the process of the ca- 
talytic hydrogenation of 3-sulfamoylmethyl-1,2-ben- 
zisoxazole (2) two products were obtained: 2-hydr- 
oxy-α-sulfamoylacetophenone (3) and its imine 4. 
While studying the chemical properties of the hydro-
genated products the authors tried to hydrolyze the com-
pound 3. In the case of using 5 % solution of hydro- 
chloric acid an unexpected cyclic product was ob-
tained – 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) 
with the yield of 98 % (Scheme 1).
A purposeful synthesis of this heterocyclic system 
was first described by King et al. [19] (Scheme 2). 
It was based on the interaction of o-hydroxy-α-bromo- 
acetophenone (5) with hydrosulfites in the presence 
of phosphorus oxychloride.
The method proposed by W. Berbiery et al. [20] 
was similar by its logic. Authors reported the synthe-
sis of a group of stable, crystalline 1,2-benzoxathian-
4-one S-oxides 7, which could be easily obtained by 
refluxing the corresponding hydroxy ketones with four 
parts of SOCl2 for 1 h. The latter were oxidized by H2O2 
to give the target benzoxathiinones 1. Another cycli- 
zing agent used in the reaction with propiophenone 
8 was chlorosulfonic acid [21]. A drawback of the ap-
proach is the formation of a mixture of the benzo-
xathiinone 1 and its 4-Cl analog 9, which, however, 
can be easily separated (Scheme 3).
The papers [22, 23] presented a two-step synthe-
sis of compound 1 by the cyclization of salicylic al-
dehyde methanesulfonates 10 followed by the oxi-
dation of the product 11 formed. However, the total 
yield of sultone 1 in these approaches was low, only 
about 30 % (Scheme 4). Compounds 10 can be easily 
obtained from the substituted salicylic aldehydes 
by their interaction with methanesulfonyl chloride 
(Et3N, DCM, r.t.). It is worth commenting another way 
for modification of hydroxylated derivatives 11 into 
1,2-benzoxathiine 2,2-dioxides 12 using POCl3/pyri- 



























Scheme 2. Application of o-hydroxy-α-bromoacetophenone (5)  














































Scheme 3. Heterocyclizations of o-hydroxyphenylketones with thionyl chloride and chlorosulfonic acid in the synthesis of sultone 1
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as a selective carbonic anhdydrase (CA) IX and XII in-
hibitors and can be successfully applied to the treat-
ment of some cancer types [25 – 27].
Schwender et al. in 1978 patented a new way to 
the synthesis of 1,2-benzoxathiin-4(3H)-one 2,2-di-
oxide derivatives [28] (Scheme 5). According to it, 
methylsulfonates 14 were obtained by the interaction 
of the substituted methyl esters of salicylic acid 13 
with methanesulfonyl chloride in the presence of a 
base. Further heterocyclization of the latter was car-
ried out by its heating in DMF with sodium hydride 
leading to the formation of the target products 1 with 
a total yield of 59 – 76 %.
This approach has gained popularity and has been 
applied with a variety of conditions in other synthe- 
tic investigations [29 – 31]. For example, authors [29] 
performed the heterocyclization of methanesulfona- 
te 14 by the action of sodium hydride when cooling 
and modifying the conditions of the product isolation. 
Arava et al. [30] used sodium hydride in DMSO for 
cyclization (the yield of compounds 1 ranged from 
47 to 76 %). The reaction proceeded well with bromo-, 
chloro-, methoxy- and methyl-substituted derivatives 14; 
in the presence of the NO2-group the target deriva-
tives 1 could not be obtained. The use of potassium 
tert-butoxide or 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) in THF for the phenyl ester 16 cyclization al-
lowed to obtain 1,2-benzoxathiin-4(3H)one 2,2-di-
oxide (1) with the yield of 70 % [31] (Scheme 6).
A similar approach to 1,2-benzoxathiin-4(3H)-
one 2,2-dioxide derivatives was used in the study 
of Peixoto et al. [32]. The synthetic route to benzo- 
xathiinone 1 is shown in Scheme 7. The authors used 
2-methylresorcinol (17) as a starting material, which 
allowed obtaining 1 substituted in the benzene nu-
cleus. After introduction of the aldehyde group into 
the 2-methylresorcinol molecule and its conversion 
into an ester, one of the hydroxyl groups was regio- 
selectively protected with tetrahydropyran (THP). 
The free hydroxyl group reacted with methanesul-
fonyl chloride, and the resulting derivative 21 was 
cyclized by the action of sodium hydride in DMF. 
The tetrahydropyran protection was easily removed 
in the acidic medium to give 7-hydroxy-8-methyl-1,2- 
benzoxathiin-4(3H)-one 2,2-dioxide (1).
According to the synthetic routes described above 
mostly 1,2-benzoxathiin-4(3H)-one 2,2-dioxide deri- 
vatives unsubstituted in position 3 of the sultone ring 
were obtained. Although the cyclization of acetophe-
nones 6 and 8 is the way of introducing a substituent 
in position 3 of the oxathiine moiety, it is still unclear 
why various alkanesulfonyl chlorides are not used 
in the approach involving alkyl salicylates as starting 
reagents (Scheme 7).
Approaches to the synthesis of the benzoxathi-
inone heterocyclic system functionalized in posi-
tion 3 are also described in the literature. These 
synthetic pathways were studied in detail by Löwe 
et al. As a starting material in a number of studies 
3-chromonsulfonic acid chloride (25), which was ob-
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Scheme 6. The two-step synthesis of sultone 1 based on phenyl salicylate (15)
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The same authors found that the interaction of 
compound 25 with methylamine in ethanol at room 
temperature resulted in the formation of an unexpec- 
ted enaminoketone – a derivative of benzoxathiino- 
ne 26 [33] (Scheme 9). The course of the transfor-
mation 25→26 was explained by the authors as an 
ANRORC mechanism accompanied by the opening of 
the pyran cycle as the result of the nucleophilic addi-
tion of methylamine (intermediate 27) and the sub- 
sequent ring closure with the sultone nucleus formation. 
As it was shown in the latter study [34], the fusion 
of compound 25 with ammonium acetate led to the 
N-unsubstituted enaminone 28 apparently formed by 
the same ANRORC way (Scheme 9). Enaminoketone 
26 exhibits properties typical for enamines and can 
be hydrolyzed to aldehyde 29. The latter exists in the 
form of at least 2 tautomers 29A and 29B as it was 
confirmed by 1H NMR spectroscopy data.
As a continuation of these studies Löwe et al. used 

































































































Scheme 9. The recyclization of 3-chromonsulfonic acid chloride (25) with methylamine and ammonia
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ester 30, and studied its interaction with a series of 
primary and secondary amines [35] (Scheme 10). 
The reaction proceeded with the formation of enamino- 
ketones 33 by the addition-elimination mechanism 
similar to the case of sulfonyl chloride 25. Also, simi-
larly to sulfonyl chloride 25, the fusion of phenyl 
ester 30 with ammonium acetate resulted in com-
pound 28 [36].
In order to obtain enaminoketones with the struc-
ture similar to 33, another way was proposed. It con-
sisted in the interaction of aromatic enaminones 34 
with chlorosulfonic acid [37]. The result of this in-
teraction was influenced by the temperature mode 
applied to it. Thus, at room temperature sulfochlo-
rination was proceeding on the benzene ring giving 
derivative 35 (Scheme 11). When the mixture was 
heated to 150 °C, two equivalents of chlorosulfonic 
acid were involved in the reaction so that one of them 
reacted with the benzene fragment, and another brid- 
ged OH and enaminone substituents of the benzene 
ring producing 1,2-benzoxathiin-4(3H)-one 2,2-dioxi- 
des 36. The reaction of compound 36 (R1 = H) with am-
monia gave the corresponding sulfonamide 37, while 
chloro-substituted derivative 36 (R1 = Cl) was sur-
prisingly inert in this reaction, and the formation of 
the sulfonamide was not observed.
Along with the results of Löwe, W. Berbiery [20] and 
R. Meyer [21] the synthesis of 3-substituted deriva-
tives of 1,2-benzoxathine 2,2-dioxide is also presented 
in a number of studies carried out by Ghandi et al. 
Their paper [38] provide an easy-performed one-pot 
interaction of the substituted 2-hydroxybenzaldehy- 
des 38 with the 4-substituted 2-phenylethenesulfo- 
nyl chlorides 39 in DMF in the presence of DBU that 
led to the formation of benzylbenzo[e][1,2]oxathiin-
4(3H)-one 2,2-dioxides 41 (Scheme 12). Scientists also 
managed to isolate the intermediates – 2-formylphe-
nyl-2-phenylethnesulfonates 40 and to investigate 
the effect of the solvent on the cyclization process. 
In the case of DBU and DMF the above-mentioned sul-
tons were formed. The replacement of DMF with me- 
thanol gave 3-(methoxyphenylmethyl)benzo[e][1,2]- 
oxathiine 2,2-dioxides 42. The authors suggested that 
the formation of 41 and 42 proceeded via the DBU-ca- 
talyzed O-sulfonylation/intramolecular Baylis−
Hillman/1,3-H shift or dehydration tandem se-
quences, respectively.
Based on the experimental data and the results 
previously published the authors proposed the me- 
chanisms for the DBU-catalyzed intramolecular Baylis- 
Hillman reaction described. It is illustrated in Scheme 13. 
For 41, the in situ generated 40 undergoes the nu-
cleophilic addition of DBU giving the zwitter-ion A. 
The subsequent nucleophilic addition of A to the al-
dehyde group affords the intermediate B. The gene- 
rated hydroxy-derivative C in the next step is trans-
formed into the final ketone 41 by the DBU-catalyzed 











































Scheme 10. The recyclization of 3-chromonsulfonic acid phenyl ester (30) with amines
OHR1 R



































Scheme 11. The synthesis of sultone 37 involving heterocyclization of aromatic enaminones 34
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anion promotes the intramolecular Baylis-Hillman 
reaction, affording intermediates E and F. The latter 
is easily transformed into 42 through losing a hydro- 
xide-anion.
Continuing the previous studies Ghandi et al. pro- 
posed a strategy for the one-pot synthesis of biolo- 
gically interesting pentacyclic condensed 1,2-benzo- 
xathiine 2,2-dioxide derivatives. It consisted in the in-
teraction of the substituted 2-hydroxybenzaldehy- 
des 38, 2-phenylethylene sulfonyl chloride (39) and 
4-hydroxycoumarins 43 or 4-hydroxyquinoline (44) 
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Scheme 13. The mechanisms of products 41 and 42 formation
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acid (EDDA) [39] (Scheme 14). The interaction pre-
sumably proceeded through the O-sulfonylation/Knoe- 
venagel condensation/hetero-Diels-Alder reaction cas-
cade and resulted in derivatives 45 –  48. It should be 
noted that the interaction at the stage of the hetero- 
Diels-Alder reaction was non-regioselective with the par-
ticipation of oxygens of the heterodiene system in 
the positions 2 and 4.
The reactivity of 1,2-benzoxathiin-4(3H)-one 2,2- 
dioxide (1) is connected with the presence of a carbo- 
nyl group, an activated methylene group and an en-
docyclic S-O bond in its structure. It is worth noting that 
the direct introduction of substituents in the benzene 
ring of 1,2-benzoxathiin-4(3H)-one 2,2-dioxides has 
not been found in the literature. As it was shown above, 
the corresponding substituted starting compounds 
were used for the synthesis of the benzene-substi-
tuted derivatives.
The carbonyl group of 1,2-benzoxathiin-4(3H)-one 
2,2-dioxide (1) exhibits the chemical properties of ke-
tones, but currently there are only a few studies in this 
area. Arava et al. [30] showed the possibility of converting 1 
to oximes 49. The latter under the action of alkoxi- 
des undergo recyclization with the formation of 1,2- 
benzisoxazole-3-methanesulfonates 50, which are im- 
portant intermediates for the preparation of an anti-
convulsant zonisamide (Scheme 15).
Another example of the 1,2-benzoxathiin-4(3H)-
one 2,2-dioxide carbonyl group modification is the pre- 
paration of enamines. The authors [28] found condi-
tions for the interaction of compound 1 with piperi-
dine (51), which led to the formation of 4-(1-piperi- 
dinyl)benzoxathiine 2,2-dioxide (52) with the yield 
of 76 % (Scheme 16). Considering the fact that in me-
dicinal chemistry sultons are known because of their 
anti-inflammatory effects [40] the authors of the cur-
rent work studied and revealed the anti-inflamma-
tory properties of 52, which reduced carrageenan 
edema when administered intraperitoneally to rats 
(100 mg/kg).
According to the literature data, the vast majority 
of chemical transformations known for 1,2-benz- 
oxathiin-4(3H)-one 2,2-dioxide (1) occurs with the par- 

























































































Scheme 15. The recyclization of sultones 1 giving 1,2-benzisoxazole-3-methanesulfonates 50
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reactivity is due to the presence of the neighboring 
C=O and SO2-fragments. Mobility of the CH2 moiety 
hydrogens results in the keto-enol tautomerism of sul-
tone 1, which can be easily observed in its 1H NMR spect- 
rum (Fig. 3). Therefore, 1,2-benzoxathiin-4(3H)-one 
2,2-dioxide (1) can be used for synthetic purposes 
as an enolnucleophile.
Using this property Schwender et al. proposed 
an approach to the functionalization of compound 1 
in position 3, which consisted in its interaction with 
substituted isocyanates in DMF in the presence of 
sodium hydride with the formation of amides 53 
(Scheme 17) [28].
In the study on the development of medicines – 
coumarin antibiotics, inhibitors of bacterial DNA gy-
rase Peixoto et al. [32] proposed to perform a bioiso- 
steric substitution, namely to replace the coumarin 
carbonyl group with more polar SO2, expecting that 
this would increase the ability of the compound to 
inhibit the enzyme. In addition, the high polarity of 
the sulfone moiety was to provide better water solu-
bility of the compounds synthesized. For this purpose, 
glycosides with noviose sugar 54 and 55 (Scheme 18) 
were synthesized; they were further functionalized 
by the active methylene group of 1,2-benzoxathiin-
4(3H)-one 2,2-dioxide nucleus.
Compound 54 was obtained by the coupling of 1 
with the activated noviose carbonate under BF3–Et2O 
conditions. Derivative 55 was prepared by Mitsunobu’s 
coupling between pyrrole-containing noviose and sul-
tone 1 (Scheme 18).
Modification of the position 3 of 54 was perfor- 
med by its interaction with 3-chlorophenylisocyanate 
in the presence of DMAP affording the corresponding 
anilide 56 (Scheme 19), which was further subjected 
to the lithium perchlorate catalysed opening of the no- 
viosyl carbonate portion with O-propargylhydroxy-
lamine to provide a mixture of regioisomeric 3′- and 
2′-N-propargyloxycarbamates 57 and 58 in the ra-
tio 4:1, respectively. The mixture was then used in 
in vitro experiments without separation. The intro-
duction of an acetyl group in 3-position of sultone 55 
by the acetic anhydride was accompanied by the ace- 
tylation of 2′-OH of noviose. The hydrolysis of the 
2′-acetate fragment with KOMe in MeOH gave 1,2-benzo- 
oxathiin 2,2-dioxide 59.
Antibacterial properties were studied for the tar-
get derivatives 57/58 and 59. According to in vitro 
studies, compound 59 had twice the ability to inhibit 
DNA gyrase compared to a similar compound con-
taining the C=O group instead of the SO2 fragment, 
and mixture 57/58 had the same in vitro inhibitory 
potency towards DNA gyrase as the aminocoumarin 
antibiotic novobiocin produced by the actinomycete 
Streptomyces niveus. However, the sultone derivatives 
were completely devoid of the antibacterial activity 
as their high polarity had a negative effect on the mo- 
lecule ability to penetrate cell lipophilic membranes 
and thus on its antibacterial activity [32].
Taking into account the structural similarity of 
1,2-benzoxathiin-4(3H)-one 2,2-dioxide and 4-hyd- 













Scheme 16. The preparation of enamines based on sultone 1














Scheme 17. The interaction of sultone 1 with isocyanates
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at the synthesis of coumarin anticoagulant analogs. 
This was achieved by the Michael addition of the sub-
stituted benzalacetones 60 to sultone 1 (Scheme 20). 
The structure of the products isolated strongly de-
pended on the substituents in the benzene portion 
of benzalacetones. In this regard, they can exist in 
acyclic form 61 or hemiketal form 63, which is ap-
parently formed through enol form 62. The authors 
discussed the stereoselectivity of the Michael addi-



















































































































































2. KOMe, MeOH, 0°C
Scheme 19. The synthesis of promising antibacterial agents comprising 1,2-benzoxathiin-4(3H)-one 2,2-dioxide core
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two sets of signals and made a conclusion about acyc- 
lic products that comprised a proton at C-3 in quasi-
equatorial and quasi-axial positions. Ketals 64 can 
also be obtained from cyclic Michael adducts 63 by 
the ordinary procedure. To study anticoagulant pro- 
perties, the compounds obtained were orally adminis-
tered to rats (Table). As a reference drug Warfarin 
in the dose of 1.25 mg/kg was taken. Twelve hours 
after administration of a single dose (330 mg/kg) 
of the compounds under research the prothrombin 
level decreased by average 25 %. The maximum level 
of activity was observed in 24 h. It is worth mentioning 
that the dose–activity relationship was not linear (when 
the dose was decreased twice, the level of activity drop- 
ped dramatically).
Löwe et al. thoroughly studied chemical proper-
ties of 1,2-benzoxathiin-4(3H)-one 2,2-dioxides con-
taining the 3-carbaldehyde moiety or its synthetic 
analogs.
Using the methylene group reactivity of the star- 
ting sultone 1 they synthesized a building block – 4-hyd- 
roxy-1,2-benzoxathiine-3-carbaldehyde 2,2-dioxide (29), 
Table
The prothrombin time for warfarin and its SO2-analogs after oral administration to rats
Cmp R1 R2 Dose, mg/kg
Prothrombin time
12h 24h 36h 48h
61 H H 350 25.6 ± 2.0 37.9 ± 3.5 > 50 17.3 ± 1.8
61 H H 175 15.0 ± 1.0 14.6 ± 0.6 13.9 ± 0.5 –
61 Cl H 330 44.4 ± 1.5 > 50 15.9 ± 0.3 –
61 OMe H 330 24.0 ± 4.6 20.8 ± 2.3 16.6 ± 0.9 –
61 Cl Cl 330 44.7 ± 3.9 > 50 22.7 ± 7.3 –
63 Cl NO2 330 18.9 ± 0.6 30.4 ± 9.1 16.4 ± 0.6 –
63 NO2 H 330 43.8 ± 3.7 > 50 21.8 ± 10.5 –
63 CN H 315 46.8 ± 4.2 > 50 18.6 ± 2.1 –
64 NO2 H 330 32.4 ± 7.4 19.8 ± 3.1 18.1 ± 2.6 –












































R1 = R2 = H
R1 = Cl, R2 = H
R1 = OMe, R2 = H
R1 = Cl, R2 = Cl
R1 = Cl, R2 = NO2
R1 = NO2, R
2 = H
R1 = CN, R2 = Cl
61 62 63
63 64
Scheme 20. The synthesis of coumarin anticoagulant analogs
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crucial for their research by the interaction of 1 with 
N,N-dimethylformamide diethyl acetal (65) followed 
by the alkaline hydrolysis (Scheme 21) [41]. The lat-
ter, as mentioned earlier, is characterized by the exis- 
tence of two tautomeric forms 29A and 29B.
Further, the authors [41] used 4-hydroxy-1,2-ben- 
zoxathiine-3-carbaldehyde 2,2-dioxide (29) for the syn-
thesis of enamines 67 by its interaction with aniline 
or sulfamide, as well as for the preparation of hydra-
zones 68 by its interaction with hydrazine and phenyl-
hydrazine. 1,3-Dielectrophilic nature of the starting 
aldehyde 29 allowed hydrazones 68 to be cyclized 
to the condensed benzoxathiinopyrazoles 69 upon 
the subsequent heating (Scheme 22).
Considering the prospects of 4-hydroxy-1,2-ben- 
zoxathiine-3-carbaldehyde 2,2-dioxide (29) for the syn- 
thesis of condensed heterocyclic systems Löwe et al. 
used this compound in further studies to obtain 
1,2-benzoxathiin[4,3-d]pyrimidine 5,5-dioxides 70 
(Scheme 23) [42]. To form a pyrimidine ring, [3+3]- 
cyclocondensation was performed with amidine ace-
tates (formamidinium acetate and guanidinium ace-
tate) by fusing the starting compounds without the use 
of a solvent.
A range of 1,2-benzoxathiin[4,3-d]pyrimidine 5,5- 
dioxides 70 was then expanded by an approach in-
volving the ability of chromone-3-sulfonic acid phe-
nyl ester (71) to be recyclized by N-nucleophiles [36]. 
According to the mechanism proposed by the authors 
at the first stage there was 1,4-addition of amidine 
to the chromone ring with the subsequent deprotona-
tion, recyclization and formation of a condensed sys-
tem of the sultone and pyrimidine rings 70 (Scheme 24).
The ability of chromone-3-sulfonic acid phenyl 
ester (71) to recyclization transformations was also 
used by Löwe et al. to obtain a number of 1,2-benzo- 
xathiine 2,2-dioxide derivatives condensed with the py- 
ridine nucleus. Thus, in the work [43] the interaction 
of compound 71 with methyl 3-aminocrotonate (72) 
was studied. The reaction was performed by fusing 
the starting materials in the presence of sodium ace- 
tate. As a result, a mixture of two products was iso-
lated, it was separated by thin layer chromatography, 
and the compounds were identified as methyl 2-me-
thyl-1,2-benzoxathiin[4,3-b]pyridine-3-carboxylate 
5,5-dioxide (73) and methyl 1,2-benzoxathiin[4,3-b]- 
pyridine-2-acetate 5,5-dioxide (74) (Scheme 25).
In order to explain the unusual result of forming 
two products in this interaction, the authors proposed 
several mechanisms for its course. The first path in-
volves the Michael reaction, in which the C-2 atom of 














































































Scheme 23. The synthesis of 1,2-benzoxathiin[4,3-d]pyrimidine 
5,5-dioxides 70
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forming the zwitter-ion A, which is characterized by 
tautomeric equilibrium (Scheme 26). It is followed 
by sequential deprotonation (B), dehydration and 
cleavage of the phenolate anion to form the reaction 
product 73.
As for compound 74 isolated as a result of the in-
teraction studied, the authors proposed two possible 
mechanisms of its formation. According to the first 
of them the rearrangement occurs in an already clo- 
sed pyridine cycle (Scheme 27).
The second probable mechanism involves the nu-
cleophilic attack of C-2 atom of chromone 71 by the 
C-4 atom of enaminoester 72 as a result of tauto-
meric transformations of the latter (Scheme 28).
As a result of the abovementioned reaction 













































































































































Scheme 26. The mechanism of the interaction of phenyl ester 71 with methyl 3-aminocrotonate (72)
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the formation of another product – the structural iso-
mer of the compounds obtained – derivative 75. This pro-
cess is possible under the condition of the nucleophi- 
lic attack of the amino group of ester 72 on the chro- 
mone ring. However, compound 75 was neither iso-
lated nor identified (Fig. 4).
In the work [44] the authors used enaminoester 76 
having one carbon atom more than aminocrotonate 
72 in the reaction with chromone 71. As the result, they 
isolated a mixture of three compounds containing ano- 
ther possible product of similar interactions – deriva-
tive 79. The mixture was managed to be separated 
by chromatography on silica gel (Scheme 29).
The authors proposed the mechanism for this inter-
action. For compounds 77 and 78 it was consistent 
with the studies presented in [44] (Schemes 26 – 28).
The formation of compound 79, which does not 
contain a nitrogen atom in the ring, is explained by 
the primary interaction of the amino group of enamino- 
ester 76 with the C-2 atom of phenyl chromone-3-sul-
fonate (71) (Scheme 30). In this case, the reaction inter-
mediate A is deprotonated with the opening of the cycle, 
the substitution of the phenolate anion and the forma-
tion of the sultone ring (B). Intermediate B undergoes 
the hydrolytic cleavage, and the compounds obtained 
then interact with each other to form an unstable inter-
mediate C. The O – S bond breaking within C leads to dis-
closure of the sultone cycle and formation of zwitter-ion 
D from which a cyclic aldehyde E is produced by the lac-
tone ring closure. Finally, the hydrolysis of the latter leads 




































































































Scheme 28. The mechanism of the interaction of phenyl ester 71 with methyl 3-aminocrotonate (72)
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The mechanism proposed has been proven by 
the fact that enaminone 28 obtained in another way 
[36] when interacting with methyl 3-oxopentanoate 
also forms product 79. At the same time, one cannot 
exclude that enaminone 28 is the product of the in-
teraction of the starting compound 71 with ammo-
nia formed by the in situ hydrolysis of methyl 3-ami-
no-2-pentenoate (76).
Continuing the study of enaminone 28 Löwe et al. 
studied the interaction of this compound with β-ke- 
toesters 80-82 in the presence of sodium acetate under 
fusion [45] (Scheme 31). It was found that the outcome 
of such interactions strongly depended on the β-ke- 
toester used. Thus, application of 80 led to 1,4-ad-
dition intermediate A which cyclized giving dibenzo 
annulated sultone 83. The use of β-ketoester 81 led 
to the loss of selectivity. As a result of this interaction, 
the formation of three reaction products 84-86 was 
observed; they were separated by thin layer chromato- 
graphy. For esters 82, the reaction proceeded as 1,2- 
addition with the formation of condensed derivati- 
ves 87 solely. Compounds 84, 86, 87 were formed in 
accordance with mechanisms discussed before, pen-
tasubstituted benzene 85 was the product of com-
pound 81 self-condensation.
In many previous studies chromone and its deri- 
vatives were used to synthesize the benzoxathiine nuc- 
leus. Therefore, it should be noted that only one work 
describes the inverse conversion of benzoxathiine 
nucleus to the chromone one [46]. It was achieved by 














































Fig. 4. Not isolated possible product of the interaction of phenyl 




















































































Scheme 30. The mechanism of compound 79 formation
Журнал органічної та фармацевтичної хімії. – 2021. – Т. 19, вип. 2 (74)
19
ISSN 2518-1548 (Online) ISSN 2308-8303 (Print)
2,2-dioxide (29) with hydroxylamine hydrochloride 
in pyridine and acetic anhydride and resulted in 
2-aminochromon-3-sulfonic acid (88) (Scheme 32). 
A stepwise format of the conversion with the pre-
liminary synthesis of oxime 89 and the subsequent 
rearrangement under the action of sodium ethoxide 
is also possible. The authors believe that the conver-
sion proceeds with the formation of acyclic interme-
diate A. Analyzing 1H NMR spectra the authors make 
a conclusion that chromone 88 is a tautomeric com-
pound and exists in 2 tautomeric forms – a predomi-
nating amino-form 88A and a minor imino-form 88B.
Another synthetic application of aldehyde 29 is 
the preparation of nitrile 91. It is a two-stage pro-
cess which requires isolation of the corresponding 
pyridinium salt 90 (Scheme 32).
The previous transformations (Scheme 32) and 















































































































Scheme 31. The interaction of enaminone 28 with β-ketoesters
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of the O–SO2 bond, which can break under basic con-
ditions. This property was used by R. Meyer [21] to 
obtain acyclic sulfonamide 93 by refluxing sultone 92 
in excess of pyrrolidine (Scheme 33).
The presence of the SO2CH2CO fragment in the mo- 
lecule of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) 
provides opportunities for the synthesis of the condensed 
heterocyclic systems based on it, but by now this syn-
thetic direction is underinvestigated. The authors [41] 
used the interaction of the starting sultone 1 with 2- 
aminobenzaldehyde in acetic acid. As a result, a new 
condensed tetracyclic system – 3,4-dihydro-1,2-ben- 
zoxathiin[4,3-b]quinoline-6,6-dioxide (94) was obtai- 
ned (Scheme 34).
Another work [29] used the SO2CH2CO fragment 
for the synthesis of new heterosteroidic systems. 
A key intermediate for this purpose – 4-oxo-3,4-di- 
hydro-2H-thiopyrano[3,2-c][1,2]benzooxathiin 5,5- 
dioxide (95) was obtained by the annelation of the thio- 
pyrane nucleus to 1 either by a direct interaction of 
the latter with β-mercaptopropionic acid or by the step- 
by-step approach with the preliminary synthesis of 
98 (Scheme 35). It is worth noting that these reac-
tions were not selective and gave rise to a mixture of 
products, which authors managed to separate.
The newly formed CH2CO fragment in 95 gave great 
opportunities to the authors to build various hetero-
cyclic moieties – pyrazole, isoxazole, pyrrole, thiazole 
(Scheme 36).
A set of works [47 – 53] were aimed at studying 
the multicomponent interaction of 1,2-benzoxathiin- 
4(3H)-one 2,2-dioxide (1), active methylene nitriles 
and carbonyl compounds in order to synthesize a new 
condensed heterocyclic system of 2-amino-3-R1-4-R2- 
4,6-dihydropyrano[3,2-c][2,1]benzoxathiine 5,5-dioxi- 
de (Fig. 5). These studies were the first and by now 
are the only investigations dedicated to the applica-
tion of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) in 
multicomponent processes. Considering the target 
dihydropyrano[3,2-c][2,1]benzoxathiine 5,5-dioxides 
as those containing 2 promising pharmacophore units 
the authors also focused on determining the biologi-
cal activity of the compounds synthesized.
The authors [47, 50 – 53] determined that the in-
teraction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide 
(1) with aldehydes 110 and malononitrile (111) gave 
a number of 2-amino-4-R-4H-pyrano[3,2-c][1,2]ben- 
zoxathiine-3-carbonitrile 5,5-dioxides 112 in mode- 
rate to high yields (Scheme 37). The interaction re-
quired a base as a catalyst, which was triethylamine 
in most cases. It was also found that in cases of ali-
phatic and alicyclic aldehydes heating was redundant 
and might lead to fail in isolation or significant de-
crease in yields of the final products. The two-step ap-
proach towards the target 2-amino-4H-pyran-3-car- 
bonitriles 112 with the use of a-cyanoacrylonitriles 
113 is also possible as shown on examples of hetero- 
aromatic aldehydes 99. However, this stepwise for-
mat has no advantages comparing to the one-pot pro-
cess as it leads to lower yields and requires more time 
to be completed.
It should be also mentioned that a successful out-
come of the reaction of the synthesis of 2-amino-4H-
pyran-3-carbonitriles 112 is limited by an aldehyde 
used. Thus, compounds 112 were not managed to be 



































































Scheme 35. The use of the SO2CH2CO fragment in sultone 1 for the synthesis of sulfur-containing condensed systems
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aldehydes (4-dimethylaminobenzaldehyde, N-methyl- 
pyrrol-2- and indol-3-carbaldehydes) or benzaldehy- 
des with bulky substituents (9-anthracencarbalde-
hyde). The only products isolated were a-cyanoacrylo- 
nitriles 113.
Taking into account the ease of forming 2-ami-
no-4H-pyran-3-carbonitriles 112 in further studies 
the authors applied ethyl cyanoacetate (114) instead 
of malononitrile in order to expand a number of the target 
condensed 2-amino-4-aryl-4H-pyrans (Scheme 38) [47]. 
However, in this case the loss of the reaction selec-
tivity was observed. The analysis of the reaction mix- 
ture by the 1H NMR method evidenced the simulta-
neous formation of the target ethyl 2-amino-4-aryl- 
4H-pyran-3-carboxylates 115, triethylammonium 
salts 116 and ethyl α-cyano-β-arylacrylates 117 
(Scheme 38). These triethylammonium salts were iso-
lated for the first time in the study on similar interac-
tions involving N-ethyl-1H-2,1-benzothiazin-4(3H)- 
one 2,2-dioxide (nitrogen-containing analogue of com-
pound 1) [54, 55]. Thus, it can be assumed that this 
chemical behavior is a common property of cyclic 
SO2-containing enolnucleophiles having a fragment 
of XSO2CH2CO.
A number of approaches was used by the authors 
in order to synthesize the target compounds 115 se-
lectively, namely the use of the ethyl cyanoacetate excess 
(its effectiveness was revealed earlier [55]), different 
heating modes, the variation of catalysts, as well 
as the two-component approach [47]. All of them were 
not successful, but the experiments carried out al-
lowed researchers to propose a possible mechanism 
of the three-component interaction (Scheme 39). 
According to it Michael adduct A, which is a recog-
nized intermediate in these interactions, can be fur-
ther transformed by two ways (Scheme 39). The first 








Fig. 5. 2-Amino-3-R1-4-R2-4,6-dihydropyrano[3,2-c][2,1]- 










































































Scheme 36. The modification ways of compound 95
Journal of Organic and Pharmaceutical Chemistry. – 2021. – Vol. 19, Iss. 2 (74)
22
ISSN 2308-8303 (Print) ISSN 2518-1548 (Online)
Ziegler reaction) and the enamine–imine tautomerism 
to form product 115. The second one is the retro-Micha- 
el reaction with the elimination of ethyl cyanoaceta- 
te (114) and the formation of enone B, which reacts 
with the second molecule of benzothiinone 1 forming 
ammonium salts 116. Apparently, the transformation 
of salt 116 into ethyl 2-amino-4H-pyran-3-carboxy- 
lates 115 is also possible by means of the reverse 
reactions.
The mechanism proposed is supported by a set 
of experiments performed in the work [47], in which 
the authors study the possibility of interconversions 
between derivatives 115, 116 and 112 (Scheme 40). 
The mutual transformations of derivatives 115 and 
116 prove reversibility of the key stages of the reac-
tion mechanism (Scheme 39). Moreover, the results 
obtained allowed explaining the facts that the 2-amino- 
4H-pyran-3-carbonitriles 112 were formed as single 
products in the three-component interaction, whereas 
the application of ethyl cyanoacetate (114) resulted 
in the isolation of the products mixture.
Based on the data obtained it was assumed that 
the formation of relatively unstable salts 116 during 
the reaction (Scheme 39) might shift the equilibrium 
towards the formation of the target 2-amino-4H-py- 
rans 115. To test this hypothesis, sodium acetate was 
used as a basic catalyst in the two-component inter-
action, assuming that the corresponding sodium salt 
116 formed under the reaction conditions would be 
less stable as compared to the triethylammonium salts. 
The use of this catalyst allowed to isolate pure ethyl 
2-amino-4-phenyl-4H-pyran-3-carboxylate 115a 
(Scheme 41). A rather unexpected result was occasio- 
nally obtained during the measurement of the 1H NMR 
spectra of 115a. This fact refers to the stability of 
ethyl 2-amino-4H-pyran-3-carboxylate 115a obtained. 
1H NMR spectra of 115a recorded 24 h and 48 h af-















R = H, Ph, 2-MeO-C6H4, 4-MeO-C6H4, 4-HO-3-MeO-C6H3,
3,4,5- MeOtri -C6H2, 2-EtO 2O-C6H4, 2-NCCH2O-C6H4,
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4-HO-C6H4, 3-HO-C6H4, 4-CF3-C6H4, 4-CH3S-C6H4, 4-NC-C6H4,
4-HO2 H4, pyridin-3-yl, pyridin-4-yl, thienyl-2, furyl-2,
1-phenyl-3-methyl-5-chloropyrazol-4-yl, 1-phenyl-3-ethoxycarbonylpyrazol-4-yl














































Scheme 38. The three-component interaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1) with aromatic aldehydes 110  
and ethyl cyanoacetate (114)
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of a high percentage of the initial benzoxathiinone 1 
and ethyl a-cyano-b-phenylacrylate (117) increasing 
over time (Fig. 6). Apparently, DMSO induces the retro- 
Michael cleavage of 115a, most probably as a result 
of its weak basic properties.
The use of hetarene-, cycloalkanecarbaldehydes 
and aliphatic aldehydes in the reaction with benzo-
xathiinone 1 and ethyl cyanoacetate (114) was also 
equivocal. In case of hetarenecarbaldehydes three dif-
ferent product types were isolated again depending 
on the aldehyde used [52]; propanal and butanal were 
the only aliphatic aldehydes for which ethyl 2-amino- 
4H-pyran-3-carboxylates were obtained [50]; cyclo- 
alkanecarbaldehydes gave no the target pyranes 115 [51] 
(Scheme 42).
Additionally, expedient two-component approaches 
were worked out for the synthesis of salts 116 and 
Hantzsch dihydropyridines 118 [47]. These routes 
are based on the interaction of benzoxathiinone 1 with 
benzaldehydes 110 in different reaction conditions 
(Scheme 43). It is interesting that dihydropyridine 
118 (Ar = Ph) is also the product of the interaction 
between benzoxathiinone 1 and benzylidene 117. 
Apparently, ammonium salt 116 initially formed un-
der the reaction conditions loses 2 molecules of wa-
ter and cyclizes into 1,4-dihydropyridine 118.
Considering isosteric relationships of the benz- 
oxathiine 1 core with other pharmacophores (Fig. 2), 
2-amino-4H-pyranes and ammonium salts presented 
in Schemes 37 – 43 were screened for the in vitro an-
timicrobial activity. The effect of the compounds on 
the blood coagulation system was also studied.
The antimicrobial activity of the compounds tested 
was moderate and more pronounced against gram-
positive bacteria than gram-negative ones and fungi 
[49-52].
Studies of the effect of the compounds synthesi- 
zed on the blood coagulation system were performed 
in vitro by the Burker method (Fig. 7) [53]. The re-
sults obtained turned out to be ambiguous. Thus, stu- 
dies showed that compounds 112f,g in the concen-
tration of 1 mg/mL significantly increased the blood 
clotting time, indicating their anticoagulant proper-
ties. It should be mentioned that the anticoagulant 
effect was not dose-dependent as the same compo- 









































































































Scheme 41. The synthesis of ethyl 2-amino-4-phenyl-4H-pyran-3-carboxylate 115a
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pronounced anticoagulant effect. Hemostatic substan- 
ces were also found among the compounds tested; 
they significantly reduced the blood clotting time com-
pared to the control.
A series of new spiro-condensed 2-amino-4H-py- 
rans were synthesized by the three-component inter-
action of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide (1), 
malononitrile (111), and cyclic carbonyls  119, 120 
in moderate to high yields (Scheme 44) [48]. When 
ethyl cyanoacetate (114) was used, the target ethyl 
2-amino-4H-pyran-3-carboxylate was obtained only 
for N-ethylisatin. Variations in catalysts, solvents and 
heating modes did not affect the efficiency of this in-
teraction.
The spiro-derivatives synthesized were studied for 
the anti-inflammatory and analgesic activities [49]. 
According to the results obtained the compounds were 
much more promising analgesic agents than anti-in-
flammatory ones. The level of anti-inflammatory acti- 
vity was significantly lower than for Piroxicam (Fig. 8), 
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Scheme 42. The use of hetarene-, cycloalkanecarbaldehydes and aliphatic aldehydes in the reaction with benzoxathiinone 1  
and ethyl cyanoacetate (114)
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Scheme 43. The synthesis of ammonium salts 116 and Hantzsch dihydropyridines 118





























Scheme 44. The synthesis of spiro-condensed 2-amino-4H-pyrans
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whereas the analgesic activity of the test substances 
was about the activity of the reference drug.
Conclusions
The analysis has shown a limited number of studies 
in each aspect – approaches to the synthesis of 1,2-ben-
zoxathiin-4(3H)-one 2,2-dioxides, their chemical trans-
formations and the study of their pharmacological 
activity. In addition to a small number of publications 
on this heterocyclic system, there have been almost no 
sultone studies in the last 20 years. Taking this into 
account 1,2-benzoxathiin-4(3H)-one 2,2-dioxide and 
its derivatives deserve close attention as objects of re- 
search for experimental chemistry and pharmacology.
Conflict of interests: the authors have no conflict 
of interests to declare.
References
1. Markitanov, Y. M.; Timoshenko, V. M.; Shermolovich, Y. G. β-Keto sulfones: preparation and application in organic synthesis. Journal of Sulfur 
Chemistry 2014, 35 (2), 188 – 236. https://doi.org/10.1080/17415993.2013.815749.
2. Roberts, D. W. Sulfonation Technology for Anionic Surfactant Manufacture. Org. Process Res. Dev. 1998, 2 (3), 194 – 202. https://doi.org/10.1021/
op9700439.
3. De Castro, S.; García-Aparicio, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Camarasa, M.-J.; Velázquez, S. 4-Benzyloxy-γ-Sultone Derivatives: Discovery 
of a Novel Family of Non-Nucleoside Inhibitors of Human Cytomegalovirus and Varicella Zoster Virus. J. Med. Chem. 2009, 52 (6), 1582 – 1591. 
https://doi.org/10.1021/jm8014662.
4. de Castro, S.; Lobatón, E.; Pérez-Pérez, M.-J.; San-Félix, A.; Cordeiro, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J.; Camarasa, M.-J.; 
Velázquez, S. Novel [2‘,5‘-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3’-spiro-5’’-(4’’-amino-1’’,2’’-oxathiole-2’’,2’’-dioxide) Derivatives with 
Anti-HIV-1 and Anti-Human-Cytomegalovirus Activity. J. Med. Chem. 2005, 48 (4), 1158 – 1168. https://doi.org/10.1021/jm040868q.
5. Xu, Y.; Zhang, Z.; Shi, J.; Liu, X.; Tang, W. Recent developments of synthesis and biological activity of sultone scaffolds in medicinal chemistry. 
Arabian Journal of Chemistry 2021, 14 (4), 103037. https://doi.org/10.1016/j.arabjc.2021.103037.
6. Mondal, S. Recent Developments in the Synthesis and Application of Sultones. Chem. Rev. 2012, 112 (10), 5339 – 5355. https://doi.org/10.1021/
cr2003294.
7. Ali, G.; Subhan, F.; Khan, I.; Islam, N. U. Input of Isosteric and Bioisosteric Approach in Drug Design. J. Chem. Soc. Pak. 2014, 36 (1), 150 – 169.
8. Thornber, C. W. Isosterism and molecular modification in drug design. Chem. Soc. Rev. 1979, 8 (4), 563 – 580. https://doi.org/10.1039/CS9790800563.
9. Au, N.; Rettie, A. E. Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants. Drug Metabolism Reviews 2008, 40 (2), 355 – 375. https://doi.org/ 
10.1080/03602530801952187.
10. Ukrainets, I. V.; Petrushova, L. A.; Dzyubenko, S. P.; Sim, G. 2,1-Benzothiazine 2,2-Dioxides. 3*. 4-Hydroxy-1-Methyl-2,2-Dioxo-N-(1,3-Thiazol-2-
yl)-1Н-2λ6,1-Benzothiazine-3-Carboxamides – a New Group of Potential Analgetics. Chem. Heterocycl. Comp. 2014, 50 (1), 103 – 110. https://
doi.org/10.1007/s10593-014-1452-0.
11. Lega, D. A.; Filimonova, N. I.; Zupanets, I. A.; Shebeko, S. K.; Chernykh, V. P.; Shemchuk, L. A. Synthesis, anti-inflammatory, analgesic and antimicrobial 
activities of ethyl 2-amino-4-alkyl-4,6-dihydropyrano[3,2-c][2,1]benzothiazin-3-carboxylate 5,5-dioxides and triethylammoniun 3-[(4-hydroxy-
1-ethyl-2,2-dioxido-1H-2,1-benzothiazin-3-yl)alkyl]-1-ethyl-1H-2,1-benzothiazin-5-olat 2,2-dioxides. Journal of Organic and Pharmaceutical 
Chemistry 2016, 14 (4), 3 – 11. https://doi.org/10.24959/ophcj.16.900.
12. Majumdar, K. C.; Mondal, S.; Ghosh, D. Synthesis of tricyclic and tetracyclic sultones by Pd-catalyzed intramolecular cyclization. Tetrahedron Lett. 
2009, 50 (33), 4781 – 4784. https://doi.org/10.1016/j.tetlet.2009.06.028.
13. Metz, P.; Fleischer, M. Intramolecular Diels-Alder Reaction of Vinylsulfonates Possessing an Acyclic Diene Moiety. Synlett 1993, 1993 (06), 
399 – 400. https://doi.org/10.1055/s-1993-22469.
14. Karsch, S.; Freitag, D.; Schwab, P.; Metz, P. Ring Closing Metathesis in the Synthesis of Sultones and Sultams. Synthesis 2004, 2004 (10), 1696 – 1712. 
https://doi.org/10.1055/s-2004-822408.
15. Karsch, S.; Schwab, P.; Metz, P. Synthesis of Sultones by Ring Closing Metathesis. Synlett 2002, 2002 (12), 2019 – 2022. https://doi.org/ 
10.1055/s-2002-35560.
Fig. 8. The anti-inflammatory and analgesic activity of 2-amino-4H-pyran-3-carbonitriles 121
Журнал органічної та фармацевтичної хімії. – 2021. – Т. 19, вип. 2 (74)
27
ISSN 2518-1548 (Online) ISSN 2308-8303 (Print)
16. John, J. P.; Novikov, A. V. Selective Formation of Six-Membered Cyclic Sulfones and Sulfonates by C−H Insertion. Org. Lett. 2007, 9 (1), 61 – 63. 
https://doi.org/10.1021/ol062592h.
17. Wolckenhauer, S. A.; Devlin, A. S.; Du Bois, J. δ-Sultone Formation Through Rh-Catalyzed C−H Insertion. Org. Lett. 2007, 9 (21), 4363 – 4366. 
https://doi.org/10.1021/ol701950d.
18. Uno, H.; Kurokawa, M. Studies on 3-Substituted 1, 2-Benzisoxazole Derivatives. VII. Catalytic Reduction of 3-Sulfamoylmethyl-1, 2-benzisoxazole 
and Reactions of the Resulting Products. Chem. Pharm. Bull. 1982, 30 (1), 333 – 335. https://doi.org/10.1248/cpb.30.333.
19. King, L. C.; Ostrum, G. K. Selective Bromination with Copper(II) Bromide. J. Org. Chem. 1964, 29 (12), 3459 – 3461. https://doi.org/10.1021/
jo01035a003.
20. Barbieri, W.; Bernardi, L.; Coda, S.; Vigevani, A. Synthesis and reactions of 1,2-benzoxathian-4-one 2-oxides. Tetrahedron Lett. 1971, 12 (52), 
4913 – 4914. https://doi.org/10.1016/S0040-4039(01)97587-2.
21. Meyer, R. F. Some novel cyclizations of propiophenones with chlorosulfonic acid. J. Heterocycl. Chem. 1966, 3 (2), 174 – 177. https://doi.org/ 
10.1002/jhet.5570030213.
22. Claney, J.; Alice, G.; Timoney, R. Int. J. Sulfur Chem., Part A. 1972, 2, 249 – 255.
23. Rehse, K.; Tenczer, J. Gerinnungsphysiologische Aktivität von 1,2-Benzoxathiinen. Arch. Pharm. 1980, 313 (3), 249 – 254. https://doi.org/ 
10.1002/ardp.19803130310.
24. Grandane, A.;  Belyakov, S.;  Trapencieris, P.; Zalubovskis, R. Facile synthesis of coumarin bioisosteres—1,2-benzoxathiine 2,2-dioxides. Tetrahedron 
2012, 68 (27), 5541 – 5546. https://doi.org/10.1016/j.tet.2012.04.080.
25. Grandane, A.;  Tanc, M.;  Zalubovskis, R.; Supuran, C. T. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated 
carbonic anhydrases IX and XII. Bioorg. Med. Chem. Lett. 2014, 24 (5), 1256 – 1260. https://doi.org/10.1016/j.bmcl.2014.01.076.
26. Grandane, A.;  Tanc, M.;  Di Cesare Mannelli, L.;  Carta, F.;  Ghelardini, C.;  Žalubovskis, R.; Supuran, C. T. 6-Substituted Sulfocoumarins Are Selective 
Carbonic Anhdydrase IX and XII Inhibitors with Significant Cytotoxicity against Colorectal Cancer Cells. J. Med. Chem. 2015, 58 (9), 3975 – 3983. 
http://doi.org/10.1021/acs.jmedchem.5b00523.
27. Grandane, A.;  Tanc, M.;  Žalubovskis, R.; Supuran, C. T. Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhy-
drase inhibitory action. Bioorg. Med. Chem. 2015, 23 (7), 1430 – 1436. https://doi.org/10.1016/j.bmc.2015.02.023.
28. Schwender, Ch. F.; Sunday, B. R. 1,2-Benzoxathiin-2,2-dioxides. US4116961A, Sep 26, 1978.
29. Cecchetti, V.; Fravolini, A.; Fringuelli, R.; Schiaffella, F. New Heterocyclic Ring System. XIV. 7,11-Dithiaoxasteroids Analogues. Heterocycles 1984, 
22 (10), 2293 – 2300. https://doi.org/10.3987/R-1984-10-2293.
30. Arava, V. R.; Siripalli, U. B. R.; Nadkarni, V.; Chinnapillai, R. Beilstein J. Org. Chem. 2007, 3 (20).  https://doi.org/10.1186/1860-5397-3-20.
31. Allegrini, P.; Bologna, A.; Castaldi, G.; Lucchini, V.; Mantegazza, S.; Razzetti, G. Process for the preparation of benzo[d]isoxazol-3-yl-methanesul-
fonic acid and the intermediates thereof. US20080081914A1, Apr 03, 2008.
32. Peixoto, C.; Laurin, P.; Klich, M.; Dupuis-Hamelin, C.; Mauvais, P.; Lassaigne, P.; Bonnefoy, A.; Musicki, B. Synthesis of isothiochroman 2,2-dioxide and 
1,2-benzooxathiin 2,2-dioxide gyrase B inhibitors. Tetrahedron Lett. 2000, 41 (11), 1741 – 1745. https://doi.org/10.1016/S0040-4039(00)00044-7.
33. Löwe, W.; Müller-Menke, C. Notiz zur Synthese von 1,2-Benzoxathiin-2,2-dioxid-Derivaten aus 3-Chromonsulfonsäure. Liebigs Ann. Chem. 1984, 
1984 (7), 1395 – 1397. https://doi.org/10.1002/jlac.198419840716.
34. Löwe, W.; Matzanke, N.; Rütjes, T. Synthesen von Chromon-3-sulfonylharnstoffen. Arch. Pharm. 1994, 327 (12), 819 – 823. https://doi.org/ 
10.1002/ardp.19943271213.
35. Löwe, W.; Jeske, P. 3,4-Dihydro-6-methyl-1,2-benzoxathiin-2,2-dioxid-Derivate mit Enaminketon-Strukturen aus 6-Methyl-4-chromon-3-sulfon-
säure-phenylester. Liebigs Ann. Chem. 1985, 1985 (10), 2012 – 2016. https://doi.org/10.1002/jlac.198519851009.
36. Löwe, W.; Jeske, P. Umsetzungen von 4-Chromon-3-sulfonsäure-phenylester mit Amidinen. Liebigs Ann. Chem. 1986, 1986 (6), 1124 – 1126. 
https://doi.org/10.1002/jlac.198619860617.
37. Löwe, W.; Braden, T. Umsetzung von aromatischen Enaminonen mit Chlorsulfonsäure. Arch. Pharm. 1991, 324 (6), 385 – 387. https://doi.org/ 
10.1002/ardp.19913240614.
38. Ghandi, M.; Bozcheloei, A. H.; Nazari, S. H.; Sadeghzadeh, M. Solvent-Dependent Reactions for the Synthesis of β-Keto-Benzo-δ-Sultone Scaffolds 
via DBU-Catalyzed O-Sulfonylation/Intramolecular Baylis–Hillman/1,3-H Shift or Dehydration Tandem Sequences. J. Org. Chem. 2011, 76 (24), 
9975 – 9982. http://doi.org/10.1021/jo201506d.
39. Ghandi, M.; Taghi Nazeri, M.; Kubicki, M. An efficient one-pot, regio- and stereoselective synthesis of novel pentacyclic-fused pyrano[3,2-c]chrome-
none or quinolinone benzosultone derivatives in water. Tetrahedron 2013, 69 (24), 4979 – 4989. https://doi.org/10.1016/j.tet.2013.04.018.
40. Li, B.; Yan, W.; Zhang, C.; Zhang, Y.; Liang, M.; Chu, F.; Gong, Y.; Xu, B.; Wang, P.; Lei, H. New Synthesis Method for Sultone Derivatives: Synthesis, 
Crystal Structure and Biological Evaluation of S-CA. Molecules 2015, 20 (3), 4307 – 4318. https://doi.org/10.3390/molecules20034307.
41. Löwe, W.; Müller-Menke, C. Reaktionen des 4-Hydroxy-1,2-benzoxathiin-3-carbaldehyd-2,2-dioxids mit Aminen und Hydrazinen. Arch. Pharm. 
1988, 321 (10), 755 – 756. https://doi.org/10.1002/ardp.19883211013.
42. Löwe, W.; Müller-Menke, C. 1,2-Benzoxathiino[4,3-d]pyrimidin-5,5-dioxide. Arch. Pharm. 1985, 318 (10), 954 – 956. https://doi.org/10.1002/
ardp.19853181019.
43. Löwe, W.; Jeske, P.; Kradepohl, A. An unusual ring transformation: Reaction of phenyl 4-chromone-3-sulfonate with methyl 3-aminocrotonate. 
J. Heterocycl. Chem. 1988, 25 (2), 699 – 701. https://doi.org/10.1002/jhet.5570250263.
44. Löwe, W.; Kradepohl, A. Michael additions with an enaminoester: Reaction of phenyl 4-chromone-3-sulfonate with methyl 3-amino-2-pentenoate. 
J. Heterocycl. Chem. 1989, 26 (3), 753 – 756. https://doi.org/10.1002/jhet.5570260345.
45. Löwe, W.; Kradepohl, A. 1,2- und 1,4-Additionen methylen-aktiver Verbindungen an ein heterocyclisches Enaminon. Arch. Pharm. 1990, 323 (12), 
987 – 989. https://doi.org/10.1002/ardp.19903231209.
46. Löwe, W.; Göbel, S.; Müller-Menke, C. Über eine Benzoxathiin-Chromon-Ringtransformation. Arch. Pharm. 1988, 321 (10), 729 – 730. https://doi.org/ 
10.1002/ardp.19883211006.
47. Grygoriv, G. V.;  Lega, D. A.;  Chernykh, V. P.;  Zaprutko, L.;  Gzella, A. K.;  Pawełczyk, A.; Shemchuk, L. A. 1,2-Benzoxathiin-4(3H)-one 2,2-dioxide – 
new enol nucleophile in three-component interaction with benzaldehydes and active methylene nitriles. RSC Adv. 2018, 8, 37295 – 37302. 
https://doi.org/10.1039/c8ra06801a.
48. Grygoriv, G. V.;  Lega, D. A.;  Zaprutko, L.;  Gzella, A. K.;  Wieczorek-Dziurla, E.;  Chernykh, V. P.; Shemchuk, L. A. Synthesis of novel spiro-con-
densed 2-amino-4H-pyrans based on 1,2-benzoxathiin-4(3H)-one 2,2-dioxide. Chem. Heterocycl. Comp. 2019, 55 (3), 254 – 260. https://doi.org/ 
10.1007/s10593-019-02450-4.
49. Grygoriv, G. V.;  Lega, D. A.;  Zupanets, I. A.;  Shebeko, S. K.;  Zimin, S. M.;  Starchikova, I. L.; Shemchuk, L. A. Spiro[benzo[е]pyrano[3,2-c][1,2]
oxathiin-4,3’-indolil]-3-carbonitrile 5,5-dioxides: synthesis and the biological activity study. Journal of Organic and Pharmaceutical Chemistry 
2019, 17 (4), 53 – 61. https://doi.org/10.24959/ophcj.19.182954.
Journal of Organic and Pharmaceutical Chemistry. – 2021. – Vol. 19, Iss. 2 (74)
28
ISSN 2308-8303 (Print) ISSN 2518-1548 (Online)
50. Grygoriv, G. V.; Lega, D. O.; Chernykh, V. P.; Osolodchenko, T. P.; Shemchuk, L. A. Synthesis of 1,2-benzoxathiine 2,2-dioxide derivatives using ali-
phatic aldehydes and assessment of their antimicrobial activity. Journal of Organic and Pharmaceutical Chemistry 2017, 15 (4), 33 – 10. https://
doi.org/10.24959/ophcj.17.927.
51. Grygoriv, G.; Lega, D.; Chernykh, V.; Osolodchenko, T.; Shemchuk L. Cycloalkanecarbaldehydes in synthesis of novel 1,2-benzoxathiin4(3H)-one 
2,2-dioxide derivatives and study of the antimicrobial activity of synthesized compounds. ScienceRise: Pharmaceutical Science 2017, 6, 4 – 10. 
https://doi.org/10.15587/2519-4852.2017.119279.
52. Grygoriv, G. V.; Lega, D. A.; Chernykh, V. P.; Osolodchenko, T. P.; Shemchuk L. A. Domino-reactions of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide, 
hetarenecarbaldehydes and active methylene nitriles in the construction of new 2-amino-4H-pyrans and investigation of their antimicrobial 
properties. Journal of Organic and Pharmaceutical Chemistry 2018, 16 (1), 3 – 10. https://doi.org/10.24959/ophcj.18.931.
53. Grygoriv, G. V.; Lega, D. A.; Shemchuk, L. M.; Maloshtan, L. M.; Kalenichenko, G. S.; Chernykh, V. P.; Shemchuk, L. A. The synthesis of 2-amino-
4-aryl-4H-pyrano[3,2-c][1,2]benzoxathiine-3-carbonitrile 5,5-dioxides and the study of their effect on the blood coagulation process. News of 
Pharmacy 2018, 4, 3 – 8. https://doi.org/10.24959/nphj.18.2224.
54. Lega, D. A.; Gorobets, N. Y.; Chernykh, V. P.; Shishkina, S. V.; Shemchuk, L. A. Peculiarities of 2-amino-3-R-4-aryl-4H-pyranes multicomponent syn-
thesis derived from 1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide. RSC Adv. 2016, 6 (19), 16087 – 16099. https://doi.org/10.1039/c5ra24566d.
55. Lega, D. A.; Chernykh, V. P.; Shemchuk, L. A. The study of three-component interaction between 1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide, 
heterylcarbaldehydes and active methylene nitriles. Journal of Organic and Pharmaceutical Chemistry 2016, 14 (1), 6 – 16. https://doi.org/ 
10.24959/ophcj.16.876.
Received: 12. 05. 2021
Revised:  02. 06. 2021 
Accepted:  05. 06. 2021
The work is a part of researches of the National University of Pharmacy on the topic «Organic synthesis and analysis of biologically  
active compounds, drugs development on the basis of synthetic substances» (the state registration No. 01144000943;  
the research period 2019 – 2024)
